References
Burdick R, Coffey T, Gutka H, Gratzl G, Conlon HD, Huang CT, et al. Statistical approaches to assess biosimilarity from analytical dat. AAPS J. 2016; In press.
Dong X, Weng YT, Tsong Y. Adjustment for imbalanced sample size for analytical biosimilar equivalence assessment. J Biopharm Stat. 2016; In press.
Chen YM, Weng YT, Dong X, Tsong Y. Wald tests for variance-adjusted equivalence assessment with normal endpoints. J Biopharm Stat. 2016; In press.
Dong X, Bian YY, Tsong Y. Statistical approaches for equivalence test with random margin. J Biopharm Stat. 2016; Submitted.
Shen M, Wang T, Tsong Y. Statistical consideration regarding to cor- related lots in analytical biosimilar equivalence test. J Biopharm Stat. 2016; In press.
Author information
Authors and Affiliations
Corresponding author
Additional information
See related article, doi:10.1208/s12248-016-9968-0.
This article reflects the views of the author and should not be construed to represent FDA’s views or policies.
Rights and permissions
About this article
Cite this article
Tsong, Y., Xia, Q. & Weng, YT. Commentary on “Statistical Approaches to Assess Biosimilarity from Analytical Data” by Burdick et al [1] . AAPS J 19, 15–17 (2017). https://doi.org/10.1208/s12248-016-9987-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12248-016-9987-x